Beyond the Scale: The Ozempic Effect
First identified in the 1970s, GLP-1 medications have shaped diabetes treatments. But in recent years, the use of these drugs to help with weight loss has been revolutionary while also raising questions on safety.In Beyond the Scale: The Ozempic Effect, hosts Terry Turner and…
- Indexed episodes, last 90 days
- 2
- Latest publication
- Sep 8, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 4, 2026
Latest episodes
Big Tech on Trial: Inside Meta's Landmark Settlement and What It Means for Your Kids (opens the original)
Read excerpt
Meta, the company behind Instagram and Facebook, has spent years in courtrooms arguing that its platforms are safe and not addictive for kids. But local governments and individuals have taken the social media giant to court, claiming that its digital products are responsible for a mental health crisis unfolding across the country. On August 26, 2026, Meta agreed to pay up to $18 billion to resolve lawsuits brought by dozens of state attorneys general. As part of that deal, the company is being f
Health on Trial: Inside the Biggest Blind Spot in Beauty History (opens the original)
Read excerpt
Every single day, you probably apply lip products without a second thought. But what if the ingredients in your favorite lip gloss, lip balm or lip mask were never tested for what happens when they go into your body? And what if those same products contain microplastics? In this episode, attorney and consumer safety advocate Whitney Di Bona sits down with Laura DiGirolamo — California attorney, beauty industry insider and founder of YOM Beauty and the Lip Service Alliance — who spent over 20 yea
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.